Status:
COMPLETED
Diagnostic Accuracy Study of Indocyanine Green for Perfusion Assessment
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Erasmus Medical Center
Leiden University Medical Center
Conditions:
Hypoparathyroidism
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Background Near-infrared fluorescence guided surgery with indocyanine green (ICG) was introduced for parathyroid perfusion assessment during total thyroidectomy in 2016. ICG can visualize tissue perfu...
Eligibility Criteria
Inclusion
- Age \>18 years
- Patients undergoing ICG-guided total thyroidectomy as surgical procedure for thyroid cancer, Graves' disease or goiter
- Patients are eligible for surgery
- Patients are mentally competent
- Written informed consent
Exclusion
- Patients with known allergy for ICG or iodinated contrast
- Pregnant or lactating women
- Patients with previous neck surgery
- Patients with dialysis dependent renal failure and kidney transplant
Key Trial Info
Start Date :
November 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06579430
Start Date
November 5 2020
End Date
May 2 2024
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9700RB
2
Erasmus Medical Center Rotterdam
Rotterdam, Netherlands